切换至 "中华医学电子期刊资源库"

中华产科急救电子杂志 ›› 2017, Vol. 06 ›› Issue (04) : 216 -218. doi: 10.3877/cma.j.issn.2095-3259.2017.04.006

所属专题: 文献

专家论坛

围产儿感染B族溶血性链球菌的预后及防治
王马列1, 罗艳敏1,()   
  1. 1. 510080 广州,中山大学附属第一医院产科
  • 收稿日期:2017-07-15 出版日期:2017-11-18
  • 通信作者: 罗艳敏

Fetal and neonatal outcome and prevention of group B streptococcus intrauterine infection

Malie Wang1, Yanmin Luo1()   

  • Received:2017-07-15 Published:2017-11-18
  • Corresponding author: Yanmin Luo
引用本文:

王马列, 罗艳敏. 围产儿感染B族溶血性链球菌的预后及防治[J/OL]. 中华产科急救电子杂志, 2017, 06(04): 216-218.

Malie Wang, Yanmin Luo. Fetal and neonatal outcome and prevention of group B streptococcus intrauterine infection[J/OL]. Chinese Journal of Obstetric Emergency(Electronic Edition), 2017, 06(04): 216-218.

B族溶血性链球菌(group B streptococcus, GBS)为需氧革兰阳性链球菌,可导致多种围产期不良结局,如宫内感染、死胎、新生儿感染及新生儿死亡等。文章主要阐述GBS宫内感染的胎儿和新生儿的预后及防治。

Group B streptococcus (GBS) is a type of gram-positive streptococcal bacteria, which can cause multiple adverse pregnancy outcome, including intrauterine infection, stillbirth, neonatal infection and neonatal death. This article will review the prognosis and prevention of fetal and neonatal infection.

[1]
Barcaite E, Bartusevicius A, Tameliene R, et al. Prevalence of maternal group B streptococcal colonisation in European countries[J]. Acta Obstet Gynecol Scand, 2008, 87(3):260-271.
[2]
Lu B, Li D, Cui Y, et al. Epidemiology of group B streptococcus isolated from pregnant women in Beijing, China[J]. Clin Microbiol Infect, 2014, 20(6):370-373.
[3]
Verani JR, Mcgee L, Schrag SJ. Prevention of perinatal group B streptococcal disease revised guidelines from CDC, 2010[J]. MMWR Recomm Rep, 2010, 59(11):1-36.
[4]
曹泽毅. 中华妇产科学 [M]. 2版. 北京:人民卫生出版社,2004: 379.
[5]
孙瑜,陈倩,边旭明,等. 北京市七家三级甲等医院宫内感染病例分析[J]. 中华围产医学杂志,2009, 12(5):342-345.
[6]
Kalin A, Acosta C, J Kurinczuk J, et al. Severe sepsis in women with group B streptococcus in pregnancy: an exploratory UK national case-control study[J]. BMJ Open, 2015, 5(12):007976.
[7]
Jahromi BN, Poorarian S, Poorbarfehee S. The prevalence and adverse effects of group B streptococcal colonization during pregnancy[J]. Arch Iranian Med, 2008, 11(6):654-657.
[8]
Cousens S, Blencowe H, Stanton C, et al. National, regional, and worldwide estimates of stillbirth rates in 2009 with trends since 1995: a systematic analysis[J]. Lancet, 2011, 377:1319-1330.
[9]
Nan C, Dangor Z, Cutland CL, et al. Maternal group B streptococcus-related stillbirth: a systematic review[J]. BJOG, 2015, 122(7):1437-1445.
[10]
Doare KL, Heath PT. An overview of global GBS epidemiology[J]. Vaccine, 2013, 31 Suppl 4:7-12.
[11]
Al-Kadri HM, Bamuhair SS, Al Johani SM, et al. Maternal and neonatal risk factors for early-onset group B streptococcal disease: a case control study[J]. Int J Womens Health, 2013, 5(10):729-735.
[12]
Ahmadzia HK, Heine RP. Diagnosis and management of group B streptococcus in pregnancy[J]. Obstet Gynecol Clin N Am, 2014, 41(8):629-647.
[13]
HW Yu, HC Lin, PH Yang, et al. Group B streptococcal infection in Taiwan: maternal colonization and neonatal infection[J]. Pediatr Neonatol, 2011, 52(8):190-195.
[14]
Håkansson S, Källén K. Impact and risk factors for early-onset group B streptococcal morbidity: analysis of a national, population-based cohort in Sweden 1997-2001[J]. BJOG, 2006, 113(10):1452-1458.
[15]
Matsubara K, Hoshina K, Suzuki Y. Early-onset and late-onset group B streptococcal disease in Japan: a nationwide surveillance study, 2004-2010[J]. Int J Infect Dis, 2013, 17(11):379-384.
[16]
Money D, Allen VM, Society of Obstetrician and Gynaecologists of Canada. The prevention of early-onset neonatal group B streptococcal disease[J]. J Obstet Gynaecol Can, 2013, 35(10):939-951.
[17]
Schrag SJ, Zywicki S, Farley MM, et al. Group B streptococcal disease in the era of intrapartum antibiotic prophylaxis[J]. N Engl J Med, 2000, 342(1):15-20.
[1] 张晓宇, 殷雨来, 张银旭. 阿帕替尼联合新辅助化疗对三阴性乳腺癌的疗效及预后分析[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 346-352.
[2] 许杰, 李亚俊, 韩军伟. 两种入路下腹腔镜根治性全胃切除术治疗超重胃癌的效果比较[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 19-22.
[3] 高杰红, 黎平平, 齐婧, 代引海. ETFA和CD34在乳腺癌中的表达及与临床病理参数和预后的关系研究[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 64-67.
[4] 李代勤, 刘佩杰. 动态增强磁共振评估中晚期低位直肠癌同步放化疗后疗效及预后的价值[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 100-103.
[5] 梁孟杰, 朱欢欢, 王行舟, 江航, 艾世超, 孙锋, 宋鹏, 王萌, 刘颂, 夏雪峰, 杜峻峰, 傅双, 陆晓峰, 沈晓菲, 管文贤. 联合免疫治疗的胃癌转化治疗患者预后及术后并发症分析[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 619-623.
[6] 张志兆, 王睿, 郜苹苹, 王成方, 王成, 齐晓伟. DNMT3B与乳腺癌预后的关系及其生物学机制[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 624-629.
[7] 关小玲, 周文营, 陈洪平. PTAAR在乙肝相关慢加急性肝衰竭患者短期预后中的预测价值[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 841-845.
[8] 张润锦, 阳盼, 林燕斯, 刘尊龙, 刘建平, 金小岩. EB病毒相关胆管癌伴多发转移一例及国内文献复习[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 865-869.
[9] 陈晓鹏, 王佳妮, 练庆海, 杨九妹. 肝细胞癌VOPP1表达及其与预后的关系[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 876-882.
[10] 刘郁, 段绍斌, 丁志翔, 史志涛. miR-34a-5p 在结肠癌患者的表达及其与临床特征及预后的相关性研究[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(06): 485-490.
[11] 陈倩倩, 袁晨, 刘基, 尹婷婷. 多层螺旋CT 参数、癌胚抗原、错配修复基因及病理指标对结直肠癌预后的影响[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(06): 507-511.
[12] 曾明芬, 王艳. 急性胰腺炎合并脂肪肝患者CT 与彩色多普勒超声诊断参数与其病情和预后的关联性研究[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(06): 531-535.
[13] 沈炎, 张俊峰, 唐春芳. 预后营养指数结合血清降钙素原、胱抑素C及视黄醇结合蛋白对急性胰腺炎并发急性肾损伤的预测价值[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(06): 536-540.
[14] 董佳, 王坤, 张莉. 预后营养指数结合免疫球蛋白、血糖及甲胎蛋白对HBV 相关慢加急性肝衰竭患者治疗后预后不良的预测价值[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(06): 555-559.
[15] 王景明, 王磊, 许小多, 邢文强, 张兆岩, 黄伟敏. 腰椎椎旁肌的研究进展[J/OL]. 中华临床医师杂志(电子版), 2024, 18(09): 846-852.
阅读次数
全文


摘要


AI


AI小编
你好!我是《中华医学电子期刊资源库》AI小编,有什么可以帮您的吗?